{"version":"1.0","provider_name":"ZMUni Compliance Centre","provider_url":"https:\/\/www.zmuni.com\/en\/","author_name":"kim","author_url":"https:\/\/www.zmuni.com\/en\/news\/author\/kim\/","title":"China's NCI Approval Updates: Targeted Plant Cell Culture Innovation and Cyclic Peptides","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"yuSaD0NcoC\"><a href=\"https:\/\/www.zmuni.com\/en\/news\/chinasnciapprovalupdatestargetedplantcellcultureinnovationan\/\">China's NCI Approval Updates: Targeted Plant Cell Culture Innovation and Cyclic Peptides<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.zmuni.com\/en\/news\/chinasnciapprovalupdatestargetedplantcellcultureinnovationan\/embed\/#?secret=yuSaD0NcoC\" width=\"600\" height=\"338\" title=\"&#8220;China&#039;s NCI Approval Updates: Targeted Plant Cell Culture Innovation and Cyclic Peptides&#8221; &#8212; ZMUni Compliance Centre\" data-secret=\"yuSaD0NcoC\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/cdn.zmuni.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/cdn.zmuni.com\/wp-content\/uploads\/2026\/05\/1779689232-43.jpg","thumbnail_width":2560,"thumbnail_height":1440,"description":"&nbsp; From May 13 to 22, 2026, 7 new cosmetic ingredients (NCIs) have completed notifications with China&#39;s National Medical Products Administration (NMPA). &nbsp;&nbsp; &nbsp; Plant &amp; Biotech &nbsp; Notification 20260084 - Saussurea Involucrata Callus Extract This NCI was notified by a subsidiary of Veminsyn Biotech (Zhejiang), with compliance support provided by ZMUni Compliance Center. ZMUni previously assisted Veminsyn Biotech in successfully notifying another NCI, Epiphyllum oxypetalum Callus Extract, continuing to safeguard the compliant commercialization of the company&#39;s innovations. &nbsp; The primary active components of Saussurea involucrata are flavonoids and polysaccharides, alongside alkaloids, organic acids, ceramides, volatile oils, trace elements, and"}